Spironolactone Alcohol Interaction Profile: What Clinicians and Patients Need to Know

Does alcohol interact with spironolactone?

The current Aldactone prescribing information does not name alcohol among the drugs it flags. Its drug interactions section lists potassium supplements and other potassium-raising drugs (ACE inhibitors, angiotensin receptor blockers, NSAIDs, heparin and low molecular weight heparin, trimethoprim), lithium, digoxin immunoassays, cholestyramine, aspirin, abiraterone and mitotane [1].

The useful comparison is between what spironolactone does on its own and what alcohol does on its own.

What the label warns about

Blood pressure and kidney function. The label warns that excessive diuresis may cause symptomatic dehydration, hypotension and worsening renal function, particularly in salt-depleted patients or those taking an ACE inhibitor or ARB, and directs prescribers to monitor volume status and renal function periodically [1]. Dizziness, headache, drowsiness, lethargy and mental confusion all appear on the label's list of reported adverse reactions [1].

Potassium. Spironolactone retains potassium as part of how it works, and the label warns about hyperkalemia, with risk increased by impaired renal function, potassium supplements, potassium-containing salt substitutes and potassium-raising drugs such as ACE inhibitors and ARBs [1]. It directs a serum potassium check within 1 week of starting or titrating the dose and regularly thereafter, with more frequent checks in kidney impairment or when other potassium-raising drugs are used [1]. The label also lists hyponatremia, hypomagnesemia, hypocalcemia, hypochloremic alkalosis and hyperglycemia among the metabolic abnormalities it can cause [1].

What alcohol does to blood pressure

A Cochrane review pooled 32 randomized trials with 767 participants (642 men, mean age 33) comparing a single dose of alcohol with placebo [5]. For low-dose alcohol, under 14 g within six hours, two trials with 28 participants found no effect on blood pressure [5].

The long-term picture is not simply that alcohol lowers blood pressure. A review of alcohol-induced hypertension describes the established association between high alcohol consumption and hypertension, with proposed mechanisms including stimulation of the renin-angiotensin-aldosterone system and endothelial injury that reduces nitric oxide-mediated relaxation [2]. Heavy alcohol intake is listed among the factors that contribute to resistant hypertension [3], reducing or avoiding alcohol is part of the lifestyle advice for resistant hypertension [6], and spironolactone is recommended as a fourth-line drug for that condition [7].

Hypertension is an approved use of spironolactone, as add-on therapy [1].

Why cirrhosis is a different case

The label warns that in hepatic disease with cirrhosis and ascites, spironolactone can cause sudden shifts in fluid and electrolytes that may precipitate impaired neurological function, worsening hepatic encephalopathy and coma [1]. For edema in cirrhosis, the label directs that treatment start in a hospital setting at 100 mg daily, with a range of 25 to 200 mg [1].

Alcohol use disorder accounts for approximately 45% of cirrhosis in the United States [8].

Acne doses and what the acne trials measured

Acne is not a labeled indication for spironolactone; the approved uses are heart failure, add-on therapy for hypertension, edema in cirrhosis or nephrotic syndrome, and primary hyperaldosteronism [1].

The SAFA trial randomized 410 women with facial acne persisting at least 6 months to spironolactone 50 mg daily until week 6, then 100 mg daily until week 24, or matching placebo, with usual topical treatment continued in both groups [4]. Headache was reported by 20.4% on spironolactone versus 12.0% on placebo, and there were no serious adverse reactions [4]. In a separate retrospective study of 974 healthy young women taking spironolactone for acne, 13 of 1,802 potassium measurements were abnormal (0.72%), against a baseline rate of 0.76% in 1,165 comparison women [9]. The Aldactone label itself still says to monitor potassium, within 1 week of starting [1].

Half-lives

The label reports a half-life of about 1.4 hours for spironolactone itself but 16.5 hours for canrenone, 13.8 hours for TMS and 15 hours for HTMS. Peak levels of spironolactone and canrenone occur at 2.6 and 4.3 hours, and metabolites are excreted mainly in urine and secondarily in bile [1].

Other drugs that carry the same label warnings

The label names NSAIDs both as drugs that can raise potassium and as drugs that can reduce spironolactone's diuretic, natriuretic and antihypertensive effect [1]. Acetylsalicylic acid may reduce the efficacy of spironolactone [1]. The label also says to check serum potassium when ACE inhibitor or ARB therapy is altered in someone taking spironolactone [1].